AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India flag India · Delayed Price · Currency is INR
9,790.00
-94.00 (-0.95%)
Jun 6, 2025, 3:29 PM IST

AstraZeneca Pharma India Revenue

In the fiscal year ending March 31, 2025, AstraZeneca Pharma India had annual revenue of 17.16B INR with 32.48% growth. AstraZeneca Pharma India had revenue of 4.80B in the quarter ending March 31, 2025, with 25.39% growth.

Revenue
17.16B
Revenue Growth
+32.48%
P/S Ratio
14.26
Revenue / Employee
28.60M
Employees
600
Market Cap
244.80B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202517.16B4.21B32.48%
Mar 31, 202412.96B2.93B29.17%
Mar 31, 202310.03B1.97B24.50%
Mar 31, 20228.06B-79.60M-0.98%
Mar 31, 20218.14B-182.50M-2.19%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition